Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Relapse severity and recovery in early pediatric multiple sclerosis.

Fay AJ, Mowry EM, Strober J, Waubant E.

Mult Scler. 2012 Jul;18(7):1008-12. doi: 10.1177/1352458511431725. Epub 2011 Dec 19.

PMID:
22183939
2.

Are initial demyelinating event recovery and time to second event under differential control?

West T, Wyatt M, High A, Bostrom A, Waubant E.

Neurology. 2006 Sep 12;67(5):809-13. Erratum in: Neurology. 2008 Nov 25;71(22):1841.

PMID:
16966542
3.

Demyelinating events in early multiple sclerosis have inherent severity and recovery.

Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E.

Neurology. 2009 Feb 17;72(7):602-8. doi: 10.1212/01.wnl.0000342458.39625.91.

4.

Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.

Leone MA, Bonissoni S, Collimedaglia L, Tesser F, Calzoni S, Stecco A, Naldi P, Monaco F.

Mult Scler. 2008 May;14(4):485-93. doi: 10.1177/1352458507084650. Epub 2008 Jan 21.

PMID:
18208889
5.

Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.

Vercellino M, Romagnolo A, Mattioda A, Masera S, Piacentino C, Merola A, Chiò A, Mutani R, Cavalla P.

Acta Neurol Scand. 2009 Feb;119(2):126-30. doi: 10.1111/j.1600-0404.2008.01076.x. Epub 2008 Aug 5.

PMID:
18684216
6.

The onset location of multiple sclerosis predicts the location of subsequent relapses.

Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E.

J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):400-3. doi: 10.1136/jnnp.2008.157305. Epub 2008 Dec 9.

PMID:
19066192
7.

The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Calabrese M, Federle L, Bernardi V, Rinaldi F, Favaretto A, Varagnolo MC, Perini P, Plebani M, Gallo P.

Mult Scler. 2012 Feb;18(2):174-80. doi: 10.1177/1352458511418550. Epub 2011 Aug 25.

PMID:
21868488
8.

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG.

Brain. 2000 Dec;123 Pt 12:2407-22.

PMID:
11099444
9.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
10.

Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.

van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Rubio JP, Butzkueven H.

Neurology. 2009 Sep 29;73(13):1018-25. doi: 10.1212/WNL.0b013e3181b9c85e.

PMID:
19786693
11.

Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis.

Neuteboom RF, Ketelslegers IA, Boon M, Catsman-Berrevoets CE, Hintzen RQ; Dutch Study Group on Childhood Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Pediatr Neurol. 2010 Jan;42(1):53-5. doi: 10.1016/j.pediatrneurol.2009.07.013.

PMID:
20004863
12.

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.

Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.

Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270. Epub 2008 Nov 5.

PMID:
18987104
13.

Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.

Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.

J Neurol Sci. 2009 Jul 15;282(1-2):47-54. doi: 10.1016/j.jns.2008.12.034. Epub 2009 Feb 6.

PMID:
19201003
14.

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T.

Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505.

PMID:
19139299
15.

Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?

Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E.

Neurology. 2008 Sep 30;71(14):1090-3. doi: 10.1212/01.wnl.0000326896.66714.ae.

PMID:
18824673
16.

Clinical predictors of early second event in patients with clinically isolated syndrome.

Mowry EM, Pesic M, Grimes B, Deen SR, Bacchetti P, Waubant E.

J Neurol. 2009 Jul;256(7):1061-6. doi: 10.1007/s00415-009-5063-0. Epub 2009 Mar 1.

17.

Gray matter atrophy in multiple sclerosis: a longitudinal study.

Fisher E, Lee JC, Nakamura K, Rudick RA.

Ann Neurol. 2008 Sep;64(3):255-65. doi: 10.1002/ana.21436.

PMID:
18661561
18.

Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis.

Koziol JA, Feng AC.

Neuroepidemiology. 2004 Sep-Oct;23(5):217-23.

PMID:
15316247
19.

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.

Kappos L, Traboulsee A, Constantinescu C, Erälinna JP, Forrestal F, Jongen P, Pollard J, Sandberg-Wollheim M, Sindic C, Stubinski B, Uitdehaag B, Li D.

Neurology. 2006 Sep 26;67(6):944-53.

PMID:
17000959
20.

Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.

Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, Ciccarelli O, Miller DH, Chard DT.

Mult Scler. 2012 Mar;18(3):322-8. doi: 10.1177/1352458511420269. Epub 2011 Aug 30.

PMID:
21878451

Supplemental Content

Support Center